Health Research & Policy Center
Our Work | Health Research & Policy Center
Spanning health research and policy topics from costs and quality to access and equity, AIR Health Research & Policy Center researchers are working to identify important spending and utilization trends and promising policy interventions using leading-edge data science and technology tools.
Ongoing center research includes examining:
- Social determinants of health and access to oncology care among Medicare beneficiaries;
- Health care utilization and spending trends among Medicare beneficiaries with Alzheimer's disease and related dementias, including use of telehealth services and antipsychotic drugs during the COVID-19 pandemic;
- Inequities in Medicaid home and community-based services;
- Medicaid and maternal health; and
- Drug policy, use, and costs.
Explore our current work below.
Biological drugs, or biologics, are innovative therapies for people with debilitating and life-threatening diseases, but these drugs are expensive. In this Q&A, AIR’s Thiyagu Rajakannan, senior researcher and lead for Drug Coverage and Payment Practice in the Health Division at AIR, explains how lower-cost versions of these drugs and promising market, regulatory, and policy developments could ease the financial burden.
Biosimilars and Cost Saving: Will Interchangeable Biosimilars Do to Biologics What Generic Drugs Did to Brand Name Medications?
In this brief, AIR's Thiyagu Rajakannan, Merton Lee, and Ilene Harris discuss the introduction of interchangeable biosimilars, a generic form of biologics, as well as efforts to encourage their use, particularly in Medicare.
Pandemic Disproportionately Drove Dually Eligible Medicare-Medicaid Beneficiaries to Skilled Nursing Facilities: Lessons from COVID-19
Using claims data before and during the COVID-19 pandemic (2017–21), this analysis examined skilled nursing facility admissions among Medicare fee-for-service beneficiaries and found that those who were dually eligible for Medicare and Medicaid were more severely affected by the COVID public health emergency and had a more challenging recovery than Medicare-only beneficiaries.
No Signs COVID Disrupted Hypertension Medication Adherence for Medicare Beneficiaries, but Racial and Ethnic Disparities Persisted
Findings from this brief suggest that steps by Medicare to relax prescribing requirements during the pandemic, such as allowing early refills and larger quantities of medication, likely helped maintain medication adherence for high blood pressure and prevent racial and ethnic disparities in adherence from worsening.
Telehealth for Medicare Beneficiaries with Chronic Conditions: No Panacea for COVID-19 Pandemic Access Challenges
Despite rapid growth spurred by the COVID-19 pandemic, telehealth visits offset less than half of the decline in in-person visits for elderly Medicare fee-for-service beneficiaries five chronic conditions, according to this AIR study that used Medicare claims data. Additional research is needed to assess the impact of ending telehealth flexibilities on equitable healthcare access and quality.
Steep but Short: COVID-19 Pandemic-Related Spending Drop for Medicare Beneficiaries with Chronic Conditions
This study examined how spending for different categories of Medicare services—inpatient, hospital outpatient, and professional providers, including physicians, physician assistants, clinical social workers, and nurse practitioners—changed from the start of the pandemic through the end of 2021.
The purpose of this journal article was to examine the effect of the largest state Medicaid expansions in the 1990s and 2000s on all-cause, healthcare-amenable, non-healthcare-amenable, and HIV-related adult mortality using state level mortality data. The authors found no evidence that Medicaid expansions affect any of the outcomes in any of the treated states or all of them combined.
Each year, thousands of birthing people experience negative outcomes during and after childbirth that result in significant consequences to their health and well-being. Health policy researchers from AIR investigated policy considerations for states offering or considering Medicaid coverage of doulas to address those inequities and advance perinatal health equity.
To learn what happens to prices, patients, and procedures in states permitting or discontinuing the use of state Medicaid funds for abortion care, AIR gathered data from abortion providers and stakeholders in three states: two authorized to continue and one that discontinued state Medicaid coverage of abortion care.